99% Savings - Buy Just @1 Rs X
Estharil-Plus is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Estharil-Plus safe for pregnant women?
Pregnant women may experience moderate side effects from Estharil-Plus. It is best to stop taking Estharil-Plus immediately and inform your doctor if you notice any discomfort.
Is the use of Estharil-Plus safe during breastfeeding?
Estharil-Plus may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Estharil-Plus, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Estharil-Plus.
What is the effect of Estharil-Plus on the Kidneys?
Estharil-Plus is not harmful for kidneys.
What is the effect of Estharil-Plus on the Liver?
Using Estharil-Plus does not have any harmful effects on the liver.
What is the effect of Estharil-Plus on the Heart?
There are no any side effects of Estharil-Plus for the heart.
Estharil-Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Estharil-Plus unless your doctor advises you to do so -
Is this Estharil-Plus habit forming or addictive?
Forming a habit of Estharil-Plus has not been reported.
Interaction between Food and Estharil-Plus
You can take Estharil-Plus with food.
Interaction between Alcohol and Estharil-Plus
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Estharil-Plus.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1182-1183
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631